CRESTOR (rosuvastatin calcium) Ipr Patent: 6,858,618 Expiration: Jun 17, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Drug Pate…
Drug Patent Expirations for the Week of June 12, 2022 Read Post »
Annual Drug Patent Expirations for BETHKIS Bethkis is a drug marketed by Chiesi and is included in one NDA. It is available from two suppliers. There are three patents protecting…
The post New patent expiration for Chiesi drug BETHKIS appeared first on…
Annual Drug Patent Expirations for RYANODEX Ryanodex is a drug marketed by Eagle Pharms and is included in one NDA. It is available from one supplier. There are five patents…
The post New patent expiration for Eagle Pharms drug RYANODEX appeared first …
New patent expiration for Eagle Pharms drug RYANODEX Read Post »
Annual Drug Patent Expirations for ZYRTEC-D+12+HOUR Zyrtec-d 12 Hour is a drug marketed by J And J Consumer Inc and is included in one NDA. It is available from one…
The post New patent expiration for J And drug ZYRTEC-D 12 HOUR appeared first on DrugP…
New patent expiration for J And drug ZYRTEC-D 12 HOUR Read Post »
Annual Drug Patent Expirations for TRULANCE Trulance is a drug marketed by Salix and is included in one NDA. It is available from two suppliers. There are nine patents protecting…
The post New patent expiration for SALIX drug TRULANCE appeared first on…
TRULANCE (plecanatide) Salix Patent: 7,799,897 Expiration: Jun 9, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Paten…
Drug Patent Expirations for the Week of June 5, 2022 Read Post »
Annual Drug Patent Expirations for ESKATA Eskata is a drug marketed by Aclaris and is included in one NDA. There are six patents protecting this drug. This drug has twenty-nine…
The post New patent expiration for Aclaris drug ESKATA appeared first on D…
Annual Drug Patent Expirations for FYCOMPA Fycompa is a drug marketed by Eisai Inc and is included in two NDAs. It is available from one supplier. There are two patents…
The post New patent expiration for Eisai Inc drug FYCOMPA appeared first on DrugPa…
New patent expiration for Eisai Inc drug FYCOMPA Read Post »
Annual Drug Patent Expirations for MYTESI Mytesi is a drug marketed by Napo Pharms Inc and is included in one NDA. It is available from one supplier. There are three…
The post New patent expiration for Napo Pharms drug MYTESI appeared first on DrugPate…
New patent expiration for Napo Pharms drug MYTESI Read Post »
Annual Drug Patent Expirations for VIMOVO Vimovo is a drug marketed by Horizon and is included in one NDA. It is available from one supplier. There are nine patents protecting…
The post New patent expiration for Horizon drug VIMOVO appeared first on Dr…